Neurocrine Biosciences

Neurocrine Biosciences is a San Diego-based biopharmaceutical company dedicated to developing treatments for neurological and endocrine-related disorders. The company discovers, develops, and markets INGREZZA capsules, the first FDA-approved product for the treatment of adults with tardive dyskinesia (an involuntary movement disorder).